Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1917 1
1918 1
1942 1
1945 1
1946 4
1947 1
1948 1
1949 3
1952 3
1954 2
1955 2
1956 1
1957 1
1958 5
1959 4
1960 3
1961 5
1962 7
1963 9
1964 9
1965 5
1966 10
1967 3
1968 10
1969 12
1970 18
1971 15
1972 13
1973 9
1974 11
1975 15
1976 23
1977 19
1978 20
1979 19
1980 21
1981 29
1982 32
1983 14
1984 30
1985 20
1986 32
1987 52
1988 53
1989 46
1990 77
1991 90
1992 102
1993 95
1994 142
1995 157
1996 179
1997 221
1998 265
1999 328
2000 446
2001 548
2002 647
2003 739
2004 944
2005 1103
2006 1282
2007 1566
2008 1863
2009 2059
2010 2540
2011 2996
2012 3360
2013 3598
2014 3872
2015 4215
2016 4334
2017 4379
2018 4542
2019 4849
2020 5377
2021 5838
2022 5468
2023 2313

Text availability

Article attribute

Article type

Publication date

Search Results

63,058 results

Results by year

Filters applied: . Clear all
Page 1
Editorial: The role of mortalin in biology and disease.
Park JI. Park JI. Front Cell Dev Biol. 2023 Apr 11;11:1196430. doi: 10.3389/fcell.2023.1196430. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 37113770 Free PMC article. No abstract available.
Pancreatic Tumor-targeting Stemsome Therapeutics.
Park JY, Park JY, Jeong YG, Park JH, Park YH, Kim SH, Khang D. Park JY, et al. Among authors: park jh. Adv Mater. 2023 Apr 28:e2300934. doi: 10.1002/adma.202300934. Online ahead of print. Adv Mater. 2023. PMID: 37114740
Coronary Revascularization in Patients With Cancer.
Pushparaji B, Donisan T, Balanescu DV, Park JK, Monlezun DJ, Ali A, Inanc IH, Caballero J, Cilingiroglu M, Marmagkiolis K, Iliescu C. Pushparaji B, et al. Among authors: park jk. Curr Treat Options Cardiovasc Med. 2023;25(6):143-158. doi: 10.1007/s11936-023-00982-9. Epub 2023 Apr 21. Curr Treat Options Cardiovasc Med. 2023. PMID: 37143711 Free PMC article. Review.
Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial.
Kelley RK, Ueno M, Yoo C, Finn RS, Furuse J, Ren Z, Yau T, Klümpen HJ, Chan SL, Ozaka M, Verslype C, Bouattour M, Park JO, Barajas O, Pelzer U, Valle JW, Yu L, Malhotra U, Siegel AB, Edeline J, Vogel A; KEYNOTE-966 Investigators. Kelley RK, et al. Among authors: park jo. Lancet. 2023 Apr 14:S0140-6736(23)00727-4. doi: 10.1016/S0140-6736(23)00727-4. Online ahead of print. Lancet. 2023. PMID: 37075781
Extrinsic and intrinsic modulators of anaphylaxis.
Carter MC, Park J, Vadas P, Worm M. Carter MC, et al. Among authors: park j. J Allergy Clin Immunol Pract. 2023 May 23:S2213-2198(23)00551-2. doi: 10.1016/j.jaip.2023.05.015. Online ahead of print. J Allergy Clin Immunol Pract. 2023. PMID: 37230384
CRACD suppresses neuroendocrinal plasticity of lung adenocarcinoma.
Kim B, Zhang S, Huang Y, Ko KP, Zou G, Zhang J, Jun S, Kim KB, Jung YS, Park KS, Park JI. Kim B, et al. Among authors: park ji. bioRxiv. 2023 Apr 21:2023.04.19.537576. doi: 10.1101/2023.04.19.537576. Preprint. bioRxiv. 2023. PMID: 37131761 Free PMC article.
The Korea National Disability Registration System.
Kim M, Jung W, Kim SY, Park JH, Shin DW. Kim M, et al. Among authors: park jh. Epidemiol Health. 2023 May 11:e2023053. doi: 10.4178/epih.e2023053. Online ahead of print. Epidemiol Health. 2023. PMID: 37189275 Free article.
63,058 results
You have reached the last available page of results. Please see the User Guide for more information.